Chronic obstructive pulmonary disease in over 16s: diagnosis and management

Recommendation ID: NG115/3
Question: Inhaled therapies for people with COPD and asthma- What is the clinical and cost effectiveness of inhaled therapies (bronchodilators and/or inhaled corticosteroids) in people with both stable COPD and asthma?
Any explanatory notes (if applicable): Why this is important:- There are a large number of trials that look at the effectiveness of bronchodilators and/or steroids in people with COPD, but the majority of them specifically excluded people with comorbid asthma. As a result, there is a lack of evidence concerning the most clinically and cost-effective treatments for this subgroup of people with COPD. Trials that recruit people with asthma and COPD could provide this evidence and ensure that these people receive the most effective maintenance
treatments for their COPD and asthma.

Source guidance details

Comes from guidance: Chronic obstructive pulmonary disease in over 16s: diagnosis and management
Number: NG115
Date issued: December 2018

Is this a recommendation for the use of a technology only in the context of research?	No
Is it a recommendation that suggests collection of data or the establishment of a register?	No
Last Reviewed	31/12/2018